drugset / Trial / NCT05918068

Pyridoxine Effect on the Blood Glucose Level in Type 2 Diabetic Patients

NCT05918068

Completed 108 enrolled Al-Rasheed University College
RandomizedParallel-groupSingle-blindTreatment

Summary

Pyridoxal-5-phosphate (P.L.P.), the biologically active form of vitamin B6, is a coenzyme in 150 enzymatic reactions, including amino acid, carbohydrate, and lipid metabolism. Neurotransmitter production and breakdown depend on it. Additionally, it functions as an antioxidant by suppressing reactive oxygen species and mitigating the development of advanced glycation end products. Humans recycle P.L.P. from dietary B6 vitamins, and this molecule has been related to various clinically relevant diseases. Pyridoxine as an additional therapy for type 2 diabetes will be examined in this study.

Timeline

Start
2022-11-01
Primary completion
2023-04-01
Completion
2023-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyridoxine Unknown 300 mg
Background Metformin Small molecule 500 mg